To ensure this was a phenomenon shared among several Ewing sarcoma cell lines, a wider range of Ewing sarcoma cell lines with varying genetic backgrounds (TP53, CDKN2A, and STAG2 WT vs. mutant) were tested. This evidence concerns the gene CDKN2A and Ewing sarcoma.